Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 293 (24), 9248-9264
- https://doi.org/10.1074/jbc.ra117.000834
Abstract
No abstract availableKeywords
Funding Information
- Chinese Natural Science Fund (81501843)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR062012, AR068509)
- National Institutes of Health (R01 DE025659)
- National Institute of General Medical Sciences (GM109005)
- National Institute of Environmental Health Sciences (ES022781)
This publication has 91 references indexed in Scilit:
- NADPH oxidase 4 limits bone mass by promoting osteoclastogenesisJCI Insight, 2013
- The Keap1/Nrf2 Protein Axis Plays a Role in Osteoclast Differentiation by Regulating Intracellular Reactive Oxygen Species SignalingJournal of Biological Chemistry, 2013
- Signal transduction by reactive oxygen speciesThe Journal of cell biology, 2011
- Bone loss caused by iron overload in a murine model: importance of oxidative stressBlood, 2010
- PGC1 beta Mediates PPAR gamma Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone LossCell Metabolism, 2010
- Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarizationJCI Insight, 2010
- Role of mitochondrial reactive oxygen species in osteoclast differentiationAnnals of the New York Academy of Sciences, 2010
- RANKL-mediated Reactive Oxygen Species Pathway That Induces Long Lasting Ca2+ Oscillations Essential for OsteoclastogenesisPublished by Elsevier BV ,2010
- Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemiaBone, 2008
- Osteoclast differentiation and activationNature, 2003